Weiping Yu
Impact in
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Immune cells in cancer
Papers in
- Immunology 12
- Immune cells in cancer 6
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 5
- Immune Response and Inflammation 4
- Oncology 12
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Guozheng WangSimon T. AbramsCheng‐Hock TohSusan WangCaroline DartNan ZhangKarim BrohiTingting Liu
- Journals
- Journal of Cancer (3 papers)Journal of Nanobiotechnology (2 papers)World Journal of Gastroenterology (2 papers)Clinical & Translational Oncology (1 paper)Recent Patents on Anti-Cancer Drug Discovery (1 paper)
- Partner nations
- ChinaUnited KingdomBangladesh
In The Last Decade
Weiping Yu
35 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Immunology 488
- Critical Care and Intensive Care Medicine 57
- Molecular Biology 474
- Cancer Research 95
- Clinical Biochemistry 37
Countries citing papers authored by Weiping Yu
This map shows the geographic impact of Weiping Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Yu more than expected).
Fields of papers citing papers by Weiping Yu
This network shows the impact of papers produced by Weiping Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Yu. The network helps show where Weiping Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiping Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 12 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 46 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 62 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 81 | |
| 14 | 2019 | 8 | |
| 15 | 2019 | 37 | |
| 16 | 2015 | 22 | |
| 17 | Circulating Histones Are Mediators of Trauma-associated Lung Injury Hit paper breakdown → | 2012 | 444 |
| 18 | 2007 | 4 | |
| 19 | Effects of crocetin on the apoptosis and the changes of its related regulating proteins caspase-3 and Bcl-2 induced by H_2O_2 in myocardial cells | 2006 | 1 |
| 20 | 2006 | 44 |
About Weiping Yu
Weiping Yu is a scholar working on Immunology, Oncology, Hepatology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine, having authored 35 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune cells in cancer (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), RNA modifications and cancer (5 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Response and Inflammation (4 papers) and Sepsis Diagnosis and Treatment (4 papers). The work is most often cited by research in Immunology (488 citations), Critical Care and Intensive Care Medicine (57 citations), Molecular Biology (474 citations), Cancer Research (95 citations) and Clinical Biochemistry (37 citations). Weiping Yu has collaborated with scholars based in China, United Kingdom and Bangladesh. Frequent co-authors include Guozheng Wang, Simon T. Abrams, Cheng‐Hock Toh, Susan Wang, Caroline Dart, Nan Zhang, Karim Brohi, Tingting Liu, Joanna Manson and Anja Kipar. Their work appears in journals such as Journal of Cancer, Journal of Nanobiotechnology, World Journal of Gastroenterology, Clinical & Translational Oncology and Recent Patents on Anti-Cancer Drug Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.